The CGM market is an exciting, fast-growing, multibillion-dollar medtech sector, according to our new Medtech Market ...

Medtronic (NYSE: MDT) announced that Gregory L. Smith, EVP, enterprise operations, notified the company of his decision to ...

The pharma company's newer immunology drugs, Skyrizi and Rinvoq, have delivered robust sales growth that's proving to be the ...

An announcement from Medtronic ( ($MDT) ) is now available. On November 1, 2025, Medtronic announced the retirement of Gregory L. Smith, Executive ...

Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through strategic partnerships with ...

Every product we touch has a footprint. A phone, a fridge, a hospital syringe. Each begins and ends in the same place: the ...

Ullem, who has held the position for more than a decade, will transition to an advisory role after his replacement is named by mid-2026.

A Medtronic hypertension procedure that can provide last-resort treatment for a condition that affects nearly half of all U.S ...

National Medicare coverage paves the way for a larger patient population to access the blood pressure treatment, which gained ...